Clinical Research News Online
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • Press Releases
    • Post Press Releases
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Recorded Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • Clinical Trainings
    • Clinical Conferences
    • Clinical Trial Innovation Summit
    • Barnett International
  • About
    • Editorial Calendar
    • Editorial Profile
    • Contact Us
    • Submit a Story
  • SCOPE Summit
    • SCOPE Summit – US
    • SCOPE Summit – Europe
    • European Innovations Awards
 
 
 
 
  • Secret to Better Drug Discovery is Better Trials

    New England Journal of Medicine | Venture Capitalists believe that the best way to reduce drug-development costs is redesigned clinical trials.

    Feb 28, 2014
  • ePRO Technology Benefits Drug Development for Pulmonary Diseases

    Clinical Informatics News | Contributed Commentary | AstraZeneca’s 2007 launch of Symbicort was enabled by patient reported outcome data. The case study suggests more opportunities for patients in clinical trials.

    Feb 26, 2014
  • Greater Representation of African Americans Needed in Clinical Trials

    Washington Post | In an op ed, former US Surgeon General David Satcher urges higher participation by African Americans in clinical trials, writing that systematic underrepresentation of African Americans in these studies hinders our ability to understand racial health disparities.

    Feb 25, 2014
  • Cinven to Acquire Medpace for $900M

    Reuters | Private equity firm Cinven plans to acquire CRO Medpace for a little over $900 million. Reuters expects the deal to be announced as soon as today.

    Feb 24, 2014
  • «
  • 251
  • 252
  • 253
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259 (current)
  • 260
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy